Paradigm Biocapital Advisors »

Vor Biopharma shares owned by Paradigm Biocapital Advisors

Quarter-by-quarter ownership of Vor Biopharma (VOR) shares owned by Paradigm Biocapital Advisors from 13F filings

Historical chart of Paradigm Biocapital Advisors investment in Vor Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Vor Biopharma held by Paradigm Biocapital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vor Biopharma by Paradigm Biocapital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $23M 1.8M 13.08

More positions owned by Paradigm Biocapital Advisors

Nuvalent Inc-a (NUVL)
Revolution Medicines (RVMD)
Arcellx Common Stock (ACLX)
Genmab A/s Sponsored Ads (GMAB)
Tarsus Pharmaceuticals (TARS)
Abivax Sa Sponsored Ads (ABVX)
Olema Pharmaceuticals (OLMA)
Vaxcyte (PCVX)
Spdr Series Trust State Street Spd Put Option (XBI)
Cidara Therapeutics Com New (CDTX)
Edgewise Therapeutics (EWTX)
Scholar Rock Hldg Corp (SRRK)
Urogen Pharma (URGN)
Crinetics Pharmaceuticals In (CRNX)
Apogee Therapeutics (APGE)

View all positions for Paradigm Biocapital Advisors

Top funds holding Vor Biopharma

Fcpm Iii Services B.v.
Frazier Life Sciences Management
RA Capital Management
VR Adviser
Paradigm Biocapital Advisors
Dr. Jeffrey R. Jay, M.D.
Susquehanna International
Caligan Partners
Vanguard Group
BlackRock
Sphera Funds Management
Laurion Capital Management
UBS Group
FMR
Findell Capital Management

View all funds holding Vor Biopharma